91 related articles for article (PubMed ID: 8437042)
1. Home infusion of intravenous immune globulin in human immunodeficiency virus-infected children.
Poole JK
J Intraven Nurs; 1993; 16(1):18-22. PubMed ID: 8437042
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
Mofenson LM; Moye J
Pediatr Res; 1993 Jan; 33(1 Suppl):S80-7; discussion S87-9. PubMed ID: 8433880
[TBL] [Abstract][Full Text] [Related]
3. Does intravenous immune globulin have a role in HIV-infected patients?
Yap PL
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
[TBL] [Abstract][Full Text] [Related]
4. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
6. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
Stiehm ER; Fletcher CV; Mofenson LM; Palumbo PE; Kang M; Fenton T; Sapan CV; Meyer WA; Shearer WT; Hawkins E; Fowler MG; Bouquin P; Purdue L; Sloand EM; Nemo GJ; Wara D; Bryson YJ; Starr SE; Petru A; Burchett S
J Infect Dis; 2000 Feb; 181(2):548-54. PubMed ID: 10669338
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection.
Kiehl MG; Stoll R; Broder M; Mueller C; Foerster EC; Domschke W
Arch Intern Med; 1996 Dec 9-23; 156(22):2545-50. PubMed ID: 8951297
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients.
Crow ME
Am J Health Syst Pharm; 1995 Apr; 52(8):803-11. PubMed ID: 7634115
[TBL] [Abstract][Full Text] [Related]
9. [Experience with the use of immune intravenous immunoglobulin in symptomatic children with human immunodeficiency virus infection].
Jiménez E; Carrer MT; Pérez Dieppa I; Ortiz L; Fernández M
Bol Asoc Med P R; 1991 Dec; 83(12):538-42. PubMed ID: 1811606
[TBL] [Abstract][Full Text] [Related]
10. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic immune globulin in children with HIV disease.
Mofenson LM; Nugent R
N Engl J Med; 1995 Mar; 332(11):750-2. PubMed ID: 7854391
[No Abstract] [Full Text] [Related]
13. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology].
Fiori GP
Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754
[TBL] [Abstract][Full Text] [Related]
14. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
15. Home health care costs: intravenous immunoglobulin home infusion therapy.
Bielory L; Long GC
Ann Allergy Asthma Immunol; 1995 Mar; 74(3):265-8. PubMed ID: 7889384
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
Powderly WG
Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
19. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
Sante; 1999; 9(5):293-300. PubMed ID: 10657773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
